Navigation Links
EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers

nd other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's website at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the integration of Miikana and its product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

    CONTACT:

    Ginny Dunn

    EntreMed, Inc.

    Associate Director

    Corporate Communications &

    Investor Relations

    (240) 864-2643

CONTACT: Ginny Dunn, Associate Director, Corporate Commun
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
5. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
6. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
10. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
11. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
Post Your Comments:
(Date:7/29/2015)...   KaloBios Pharmaceuticals, Inc . (Nasdaq: KBIO ... therapies to benefit patients with diseases of unmet medical ... the U.S. Food and Drug Administration (FDA) has cleared ... an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic ... active. The acceptance of this IND allows ...
(Date:7/29/2015)... -- Ortho-Clinical Diagnostics, Inc. (OCD) today announced the presentation of ... a range of important tests for clinical labs including ... scientific posters will be delivered during the 2015 American ... July 26 - 30 in Atlanta, Georgia ... emerging stronger than ever since becoming a stand-alone company, ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/zcrjfz/global ... "Global Neurostimulation Devices Market 2015" report to ... global neurostimulation devices market to grow at a ... The report, Global Neurostimulation Devices Market 2015-2019, ... analysis with inputs from industry experts. The report ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2
... VirtualScopics, Inc. (NASDAQ: VSCP ), a leading provider ... $3,852,925 for the second quarter of 2011 compared to revenues ... increase. Gross profit for the quarter ended June 30, 2011 ... 30, 2010. Operating income for the second quarter of 2011 ...
... HITECH Act is a law that requires healthcare organizations to ... data is at the forefront of many leading managed hosting ... in HIPAA and HITECH compliance, has been asked to address ... a speaking session on Wednesday, August 10. "The ...
Cached Medicine Technology:VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 2VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 3VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 4VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 5VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 6VirtualScopics Reports 2nd Quarter 2011 Results; Revenues Rise 20% 7HITECH Act Puts Security of Electronic Medical Records in Hands of Hosting Providers 2
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and ... believes that Well-Being begins with understanding how the body actually works. A state of ... within. Guests will receive tips on how to forge this new relationship with their ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... a sponsor, with its Topricin® Pain Relief and Healing Cream designated as the ... web-based organization that is actively addressing Line of Duty Deaths (LODD) and the ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald on ... and mental health disorders. Acu-detox may begin taking off in the South Florida community ... alcohol addiction. Although acupuncture is not a new practice, it is not widely used, ...
(Date:7/29/2015)... ... ... For the second year in a row, the management and staff of ... growing companies in Jacksonville. This annual list is compiled by the Jacksonville Business Journal, ... Vast Bridges staffers were on hand to receive the award naming the company the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline Publications, ... of 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, both ... contains the largest and freshest searchable agriculture equipment database in the world. The ...
Breaking Medicine News(10 mins):Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2
... a nationwide Japanese encephalitis immunization programme for children from ... ,The health menace, which is caused by a ... mostly in Uttar Pradesh, in 2005 and around 1,700 ... implemented in collaboration with the World Health Organisation (WHO) ...
... are alarmed as new rules are being implemented that ... in hospitals of the National Health Service (NHS). , ... Indian subcontinent who could suddenly find themselves unemployed. In ... local doctors available the first preference will be given to ...
... pulmonary fibrosis in African-Americans is almost twice as high ... now, researchers have been searching for an explanation for ... has found why this racial difference exists. ... the lung's air sacs are replaced by tough fibrotic ...
... mother has died of a blood clot her lungs as ... Simpson's maternity// pavilion, part of the new Edinburgh Royal Infirmary, ... son. ,Doctors say that a blood clot formed ... her death. The single mother, who lived in Edinburgh's Gracemount, ...
... executives large numbers of Scots is experiencing memory loss as ... loss is associated with long-term brain damage. It can also ... rapists. ,This survey targeted young people in four ... as a result of alcohol. In Aberdeen, 100 % said ...
... most of the world's top food companies show pathetically poor ... ,The report prepared by London’s City University shows that ... had undergone very little change despite the targets set by ... of obesity, heart disease and diabetes. ,It was ...
Cached Medicine News:Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3Health News:Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks 2
TigerStick is a white #2 FiberStick with black stripes and a stiffened, 12 inch, waxed end. It is especially useful when motion determination and alternating colored sutures are required in the arthr...
... FiberLoop is a suture ... These small diameter looped FiberWire ... flexor and extensor tendon repairs ... multiple needle passes. FiberLoop is ...
... uroflow study remains the mainstay in a urologic ... and patient needs for an accurate, easy-to-use in-office ... the onset of urine flow and automatically ends ... no urine flow. There is no need to ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
Medicine Products: